Media Contact:
Lynn Tellefsen
Director of Marketing & Communications
Phone: 212.701.3614
Fax: 212.378.2410
ltellefsen@cahill.com

Legal News

Cahill Represents Financing Sources in Valeant and Biovail Merger

Date: 06/21/10

Cahill is representing the financing sources in connection with providing $2.8 billion of financing for the merger of specialty pharmaceuticals companies Valeant Pharmaceuticals International and Canada's Biovail Corp.